^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Vigil (gemogenovatucel-T)

    i
    Associations
    News
    Trials
    Company:
    Gradalis
    Drug class:
    GM-CSF agonist, TGF-β1 inhibitor, TGF-β2 inhibitor
    Related drugs:
    Associations
    News
    Trials